https://www.selleckchem.com/pr....oducts/talabostat.ht
BACKGROUND Elimination of mother to child transmission of human immune virus was a global public health priority. In 2013, the World Health Organization recommended antiretroviral therapy administration to all of human immune virus positive pregnant and breastfeeding women regardless of the CD4 cell count or clinical stage, which referred to "Option B+". Ethiopia had a high prevalence of mother to child transmission of human immune virus. The prevalence of the transmission on breastfeeding mothers was 24% in 2012. However, the preval
Curtir
Comentario
Compartilhar
